Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04188535 · ClinicalTrials.gov registry record · NA
Serial MRI Scans During Radiation Therapy
A NA study of Prostate Cancer and Glioblastoma, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 149
- Enrollment target
- 2
- Study locations
NCT04188535 is a NA study of Prostate Cancer and Glioblastoma that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 149 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04188535, a NA study of Prostate Cancer and Glioblastoma, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a phase 1 study to determine the feasibility and utility of using serial magnetic resonance imaging (MRI) to assess treatment response during and after radiation therapy (standard of care cancer treatment) for participants with advanced esophageal cancer, glioblastoma, prostate cancer, vulvar cancer or pediatric glioma. The research study procedures include three MRI scans (one before, one during, and one after standard of care cancer radiation therapy) for participants with advanced esophageal cancer, glioblastoma, prostate cancer, vulvar cancer or pediatric glioma. The research study procedures include: * Screening for eligibility * Three MRI scans
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MRI IMAGING
Study Locations (2)
Massachusetts
- Brigham and Women Hospital - Boston
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2020-01-15 |
| Est. Completion | 2030-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04188535
The ClinicalTrials.gov registry entry for NCT04188535 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI IMAGING is the first listed.
NCT04188535 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04188535 about?
NCT04188535 is a clinical study titled "Serial MRI Scans During Radiation Therapy". This is a phase 1 study to determine the feasibility and utility of using serial magnetic resonance imaging (MRI) to assess treatment response during and after radiation therapy (standard of care cancer treatment) for participants with advanced esophageal cancer, glioblastoma, prostate cancer, vulva...
What is the current status of trial NCT04188535?
This trial is currently recruiting. It is a NA study. The enrollment target is 149 participants. The study started on 2020-01-15. Estimated completion is 2030-07-31.
What conditions does trial NCT04188535 study?
This clinical trial studies the following conditions: Prostate Cancer, Glioblastoma, Esophageal Cancer, Magnetic Resonance Imaging, Vulvar Cancer.
What interventions are being tested in trial NCT04188535?
The interventions under investigation include: MRI IMAGING (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04188535?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04188535 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.